Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in NERV — Minerva Neurosciences, Inc.

CIK 1533421 NEW YORK, NY
Back to NERV Full portfolio

Position in NERV

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$20,407
+$18,393 QoQ
Shares Held
3,677
+633.9% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#48
of 58 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NERV Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,738,477 across 465 Biotechnology names. NERV ranks #244 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in NERV

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $20,407 3,677
2025-12-31 $2,014 501
2025-09-30 $2,822 1,341
2025-06-30 $3,809 2,215
2025-03-31 $4,493 2,643
2024-12-31 $3,204 1,442
2024-09-30 $5,093 1,908
2024-06-30 $7,809 2,448
2024-03-31 $10,585 4,103
2023-12-31 $8,363 1,360
2023-09-30 $18,892 2,738
2023-06-30 $11,461 1,254
2023-03-31 $1 822
2022-06-30 $13,222 3,995
2022-03-31 $3,628 4,372
2021-12-31 $6,444 8,046
2021-06-30 $40,367 17,400
2021-03-31 $31,649 10,839
2020-12-31 $33,361 14,257
2020-09-30 $117,551 36,966
2020-06-30 $24,764 6,860
2020-03-31 $13,731 2,281